Director, Market Development
Regenxbio
About this role
The Director, Market Development will lead regional strategy and commercial launch readiness for REGENXBIO’s innovative therapies in rare and neuromuscular diseases. This field-based role acts as a key connector between internal commercial and medical teams and external treatment centers and stakeholders. The position focuses on shaping and executing regional market development strategies that support treatment access and long-term growth of REGENXBIO’s products. It requires extensive travel for stakeholder engagement across assigned regions.
Skills
Qualifications
About Regenxbio
ultipro.comUltiPro (originally from Ultimate Software) is a cloud-based human capital management (HCM) platform that delivers HR, payroll, talent management, and workforce management tools for organizations. The SaaS suite includes payroll processing, benefits administration, recruiting and onboarding, performance management, time & attendance, and people analytics in a unified system. Known for strong customer support and analytics-driven HR workflows, UltiPro was developed by Ultimate Software, which merged with Kronos to form UKG (Ultimate Kronos Group) and continues in that product portfolio (often branded UKG Pro). Enterprises across industries use it to streamline HR operations and improve employee experience.
Recent company news
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
12 hours ago
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit – Company Announcement
4 hours ago
Stifel reiterates Regenxbio stock rating on Duchenne trial data
1 day ago
What is HC Wainwright's Estimate for REGENXBIO Q1 Earnings?
2 days ago
RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026
2 days ago
About Regenxbio
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Regenxbio.
Salary
$187k – $265k
per year
More jobs at Regenxbio
Similar Jobs
Director, Market Access (Rare Diseases)
Regeneron Pharmaceuticals
VP, Customer Experience
Dyne Therapeutics
Associate Director, Market Development - Mid-West
Orca Bio
Director Market Access - Rare Diseases (EU4 + UK)
Regeneron Pharmaceuticals
Country Medical Director, Germany
Scholar Rock
Portfolio Lead – Fabry and Gaucher
Sanofi